Tubulointerstitial Nephritis Antigen-Like 1 (TINAGL1) Peptide
-
- Target See all TINAGL1 products
- TINAGL1 (Tubulointerstitial Nephritis Antigen-Like 1 (TINAGL1))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- ENGPVQALME VHEDFFLYKG GIYSHTPVSL GRPERYRRHG THSVKITGWG
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of TINAGL1 antibody,
Alternative Names: TINAGL1 control peptide, TINAGL1 antibody Blocking Peptide, Anti-TINAGL1 Blocking Peptide, ARG1 Blocking Peptide, LCN7 Blocking Peptide, LIECG3 Blocking Peptide, TINAGRP Blocking Peptide, Tubulointerstitial Nephritis Antigen-Like 1 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- TINAGL1 (Tubulointerstitial Nephritis Antigen-Like 1 (TINAGL1))
- Background
- TINAGL1 may be implicated in the adrenocortical zonation and in mechanisms for repressing the CYP11B1 gene expression in adrenocortical cells. This is a non catalytic peptidase C1 family protein.
- Molecular Weight
- 52 kDa
-